Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Amir NutmanYehuda Carmeli

Abstract

Patients with carbapenem-resistant Acinetobacter baumannii-positive clinical cultures during a prior hospitalization were screened using high sensitivity methods upon first readmission. Of 38 patients, 31.6% screened positive; 42% screened positive within 2 months from discharge, and 14% screened positive more than 5 months from discharge. Carriage was persistent up to 285 days.

References

Feb 23, 2007·Journal of Clinical Microbiology·Dror MarchaimYehuda Carmeli
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
May 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E V LemosK Kawai
Sep 7, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A NutmanY Carmeli
Dec 19, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jason P BurnhamMarin H Kollef
Nov 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara TomczykStephan Harbarth

❮ Previous
Next ❯

Citations

May 15, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Frida RiveraL Silvia Munoz-Price

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

The Pediatric Infectious Disease Journal
Narongsak Nakwan, Kulkanya Chokephaibulkit
Journal of Neurosurgery
Nikolaos Sakellaridis, Vasilios Kontoyannis
The Journal of Antimicrobial Chemotherapy
Rohini J ManuelRichard Holliman
Journal of Global Antimicrobial Resistance
Yury GorbichOlga Kretchikova
© 2021 Meta ULC. All rights reserved